Craig Bijou
Stock Analyst at B of A Securities
(3.85)
# 639
Out of 4,876 analysts
62
Total ratings
64.71%
Success rate
62.01%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $56.91 | +47.60% | 4 | Apr 25, 2025 | |
| RXST RxSight | Maintains: Buy | $60 → $36 | $12.67 | +184.14% | 1 | Mar 21, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $119.47 | +17.18% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $12.40 | +37.10% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $58.60 | +65.53% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $12.29 | +46.46% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $122.56 | +18.31% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $93.50 | +10.16% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $73.80 | +15.18% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $74.38 | +15.62% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $71.14 | +33.54% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.43 | +95.33% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.37 | +606.44% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $3.35 | +3,482.09% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.45 | +450.46% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $13.22 | -1.66% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $11.09 | +278.72% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $533.71 | -56.91% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $393.55 | -41.56% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $56.91
Upside: +47.60%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60 → $36
Current: $12.67
Upside: +184.14%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $119.47
Upside: +17.18%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $12.40
Upside: +37.10%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $58.60
Upside: +65.53%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $12.29
Upside: +46.46%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $122.56
Upside: +18.31%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $93.50
Upside: +10.16%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $73.80
Upside: +15.18%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $74.38
Upside: +15.62%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $71.14
Upside: +33.54%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.43
Upside: +95.33%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.37
Upside: +606.44%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $3.35
Upside: +3,482.09%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.45
Upside: +450.46%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $13.22
Upside: -1.66%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $11.09
Upside: +278.72%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $533.71
Upside: -56.91%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $393.55
Upside: -41.56%